Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in additional lumbar posterolateral fusion: minimum 1-year follow-up
- Authors
- 강창남
- Issue Date
- 30-Aug-2024
- Place
- Yogykarta, Indonesia
- Conference Name
- ISASS AP 2024
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 정형외과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Kang, Chang Nam
- 서울 의과대학 (DEPARTMENT OF ORTHOPEDIC SURGERY)